Efficacy of adenotonsillectomy in the treatment of obstructive apnea in children: A 2-year follow-up

Pizarro, Gilberto Ulson; Costa, Emilia Leite de Barros; Pradella-Hallinan, Márcia; Meurer, Ana Taíse de Oliveira; Moreira, Gustavo Antônio; Fujita, Reginaldo Raimundo

doi:10.1016/j.ijporl.2023.111462

Cited by 1 publication

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent publications have shown that the use of adenotonsillectomy in pediatric OSA patients may have variable results, reaching an AHI of 1 or less in about 50–70% of cases, but its efficacy decreases with risk factors such as age (<7 years), severe disease, chronic asthma or obesity. Persistent disease is present in 20–75% of children, with more than half having habitual snoring [ 7 , 43 , 44 ]. In addition, other surgical procedures may be performed in selected cases, such as septoplasty, uvulopharyngopalatoplasty, epiglottoplasty, glossopexy, and maxillomandibular surgery.…”

Section: Introductionmentioning

confidence: 99%

Diagnosis and Treatment of Sleep Apnea in Children: A Future Perspective Is Needed

Solano-Pérez,

Coso,

Castillo-García

et al. 2023

Biomedicines

View full text Add to dashboard Cite

Obstructive sleep apnea (OSA) in children is a prevalent, but still, today, underdiagnosed illness, which consists of repetitive episodes of upper airway obstruction during sleep with important repercussions for sleep quality. OSA has relevant consequences in the pediatric population, mainly in the metabolic, cardiovascular (CV), and neurological spheres. However, contrary to adults, advances in diagnostic and therapeutic management have been scarce in the last few years despite the increasing scientific evidence of the deleterious consequences of pediatric OSA. The problem of underdiagnosis and the lack of response to treatment in some groups make an update to the management of OSA in children necessary. Probably, the heterogeneity of OSA is not well represented by the classical clinical presentation and severity parameters (apnea/hypopnea index (AHI)), and new strategies are required. A specific and consensus definition should be established. Additionally, the role of simplified methods in the diagnosis algorithm should be considered. Finally, the search for new biomarkers for risk stratification is needed in this population. In conclusion, new paradigms based on personalized medicine should be implemented in this population.

show abstract

Section: Introductionmentioning

confidence: 99%